Haw Par Has Announced A Dividend Of SGD0.20 - Simply Wall St
HAWPY Stock | USD 28.64 0.00 0.00% |
Slightly above 56% of Haw ParLtd's investor base is looking to short. The analysis of overall sentiment of trading Haw Par pink sheet suggests that many investors are alarmed at this time. Haw ParLtd's investing sentiment can be driven by a variety of factors including economic data, Haw ParLtd's earnings reports, geopolitical events, and overall market trends.
Haw |
Haw Par Has Announced A Dividend Of SGD0.20 Simply Wall St
Read at news.google.com
Haw ParLtd Fundamental Analysis
We analyze Haw ParLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Haw ParLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Haw ParLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Haw Par is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Haw ParLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Haw ParLtd pink sheet to make a market-neutral strategy. Peer analysis of Haw ParLtd could also be used in its relative valuation, which is a method of valuing Haw ParLtd by comparing valuation metrics with similar companies.
Peers
Haw ParLtd Related Equities
SNY | Sanofi ADR | 3.84 | ||||
RHHBY | Roche Holding | 2.55 | ||||
LLY | Eli Lilly | 2.38 | ||||
AZN | AstraZeneca PLC | 1.41 | ||||
PFE | Pfizer | 1.09 | ||||
GSK | GlaxoSmithKline PLC | 0.86 | ||||
MRK | Merck | 0.68 | ||||
JNJ | Johnson Johnson | 0.51 | ||||
ABBV | AbbVie | 0.26 | ||||
BMY | Bristol Myers | 0.15 |
Additional Tools for Haw Pink Sheet Analysis
When running Haw ParLtd's price analysis, check to measure Haw ParLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw ParLtd is operating at the current time. Most of Haw ParLtd's value examination focuses on studying past and present price action to predict the probability of Haw ParLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw ParLtd's price. Additionally, you may evaluate how the addition of Haw ParLtd to your portfolios can decrease your overall portfolio volatility.